Indication
Flank Mass
1 clinical trial
2 products
Product
RZL-012Clinical trial
A Double-Blind, Placebo-Controlled Phase Followed by An Open-Label Phase to Evaluate the Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the FlanksStatus: Completed, Estimated PCD: 2022-10-20
Product
Placebo